HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Schafer Selected Research
Peter Schafer Research Topics
Disease
9
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 11/2005
7
Neoplasms (Cancer)
11/2022 - 02/2003
7
Multiple Myeloma
01/2018 - 01/2005
6
Psoriatic Arthritis
11/2021 - 10/2010
5
Heart Failure
02/2024 - 02/2021
4
Inflammation (Inflammations)
12/2021 - 11/2009
3
Arthritis (Polyarthritis)
11/2022 - 01/2010
2
Fibrosis (Cirrhosis)
08/2023 - 01/2022
2
Rheumatoid Arthritis
12/2022 - 01/2010
2
Necrosis
12/2021 - 01/2010
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2010 - 07/2008
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2009 - 03/2006
2
Weight Loss (Weight Reduction)
11/2009 - 03/2006
2
Colonic Neoplasms (Colon Cancer)
01/2008 - 01/2005
1
Myocardial Infarction
11/2023
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
08/2023
1
Atherosclerosis
01/2022
1
Aortic Valve Stenosis (Aortic Stenosis)
12/2021
1
Oral Ulcer (Mouth Ulcer)
11/2021
1
Heart Arrest (Cardiac Arrest)
02/2021
1
Hematologic Diseases (Blood Diseases)
01/2021
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1
Ankylosing Spondylitis
01/2020
1
Metabolic Diseases (Metabolic Disease)
05/2017
1
Colorectal Neoplasms (Colorectal Cancer)
01/2011
1
Venous Thromboembolism
01/2010
1
Neutropenia
01/2010
1
Experimental Arthritis
01/2010
1
Disease Progression
11/2009
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2008
Drug/Important Bio-Agent (IBA)
11
Lenalidomide (CC 5013)
FDA Link
05/2016 - 01/2005
9
apremilast
IBA
11/2021 - 01/2010
7
Phosphodiesterase 4 Inhibitors
IBA
11/2021 - 11/2005
6
Biomarkers (Surrogate Marker)
IBA
08/2023 - 12/2019
6
Thalidomide (Thalomid)
FDA Link
05/2016 - 02/2003
5
Proteins (Proteins, Gene)
FDA Link
11/2023 - 02/2003
4
pomalidomide
IBA
05/2016 - 07/2009
3
Cytokines
IBA
01/2021 - 11/2009
3
iberdomide
IBA
01/2021 - 01/2018
2
Blood Proteins (Serum Proteins)
IBA
02/2024 - 11/2023
2
Mineralocorticoid Receptor Antagonists
IBA
11/2023 - 01/2022
2
Ligands
IBA
11/2022 - 01/2011
2
Interleukins
IBA
12/2021 - 06/2012
2
Interleukin-6 (Interleukin 6)
IBA
12/2021 - 01/2020
2
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
11/2021 - 01/2019
2
Interleukin-17 (Interleukin 17)
IBA
01/2020 - 12/2019
2
Interleukin-12 (IL 12)
IBA
01/2019 - 07/2008
2
Antigens
IBA
01/2011 - 07/2008
2
Antibodies
IBA
01/2011 - 07/2008
2
Immunomodulating Agents
IBA
01/2010 - 07/2009
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2010 - 11/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2008 - 01/2008
1
Insulin (Novolin)
FDA Link
11/2023
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2023
1
Creatinine
IBA
11/2023
1
JNK Mitogen-Activated Protein Kinases
IBA
08/2023
1
CC-90001
IBA
08/2023
1
Abatacept (Orencia)
FDA Link
12/2022
1
Anti-Citrullinated Protein Antibodies
IBA
12/2022
1
Methotrexate (Mexate)
FDA Link
Generic
12/2022
1
Antirheumatic Agents (DMARD)
IBA
12/2022
1
Collagen Type I (Type I Collagen)
IBA
12/2022
1
Interleukin-12 Subunit p40
IBA
11/2022
1
Phosphotransferases (Kinase)
IBA
11/2022
1
Peptides (Polypeptides)
IBA
11/2022
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
11/2022
1
Chemokines
IBA
11/2022
1
CXC Chemokines
IBA
11/2022
1
Chemokine CCL7
IBA
11/2022
1
Glycoproteins (Glycoprotein)
IBA
01/2022
1
Apelin
IBA
01/2022
1
Liver X Receptors
IBA
01/2022
1
Spironolactone (Aldactone)
FDA Link
Generic
01/2022
1
Endostatins
IBA
12/2021
1
pro-brain natriuretic peptide (1-76)
IBA
12/2021
1
Lipocalin-2
IBA
12/2021
1
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
12/2021
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
12/2021
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
12/2021
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
12/2021
1
Osteoprotegerin
IBA
12/2021
1
Syndecan-1 (Syndecan 1)
IBA
12/2021
1
Inflammasomes
IBA
11/2021
1
Apolipoproteins M
IBA
02/2021
1
Transcription Factors (Transcription Factor)
IBA
01/2021
1
Interleukin-23 (Interleukin 23)
IBA
12/2019
1
Adipokines
IBA
12/2019
1
C-Reactive Protein
IBA
05/2017
1
Interleukin-10 (Interleukin 10)
IBA
06/2012
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
06/2012
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2011
1
Cetuximab (Erbitux)
FDA Link
01/2011
1
Trastuzumab (Herceptin)
FDA Link
01/2011
1
Collagen Type II (Type II Collagen)
IBA
01/2010
1
Fas Ligand Protein (Fas Ligand)
IBA
11/2009
1
Dexamethasone (Maxidex)
FDA Link
Generic
07/2009
1
fludarabine
IBA
07/2008
1
IgG Receptors (Fc gamma RI)
IBA
07/2008
1
Immunoglobulin G (IgG)
IBA
07/2008
Therapy/Procedure
3
Therapeutics
01/2022 - 11/2005